Ploypin Lertjitbanjong

TL;DR: There are significant associations of post-LTx AKI with increased mortality and graft failure after transplantation and the incidence has remained stable over the ten years of the study.

TL;DR: Antifibrotic treatment was associated with decreased risk of all-cause mortality with a pooled RR of 0.55 (95% CI, 0.45-0.76), and I2 of 0%. Effect on AE risk was consistent across subgroup analyses by study type and for nintedanib but not for pirfenidone as mentioned in this paper.

TL;DR: Among patients receiving ECMO, the incidence rates of AKI and severe AKI requiring RRT are high, which has not changed over time, and patients who develop AKI require renal replacement therapy while on ECMO carry 3.7-fold higher hospital mortality.

TL;DR: It is demonstrated that anticoagulation use for AF in patients with cirrhosis is associated with a reduced risk of stroke, without increasing significantly the risk of bleeding, when compared to those without antICOagulation.

TL;DR: Despite advances in therapy, the incidence of AKI in patients after lung transplantation does not seem to have decreased and is significantly associated with reduced short-term and long-term survival.